ViaDerma, Inc. (VDRM)

Market Cap	493.49K -96.5%
Revenue (ttm)	44.69K -99.7%
Net Income	-1.52M
EPS	-0.00
Shares Out	1.23B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,725
Average Volume	70,694
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0001 - 0.0235
Beta	0.15
RSI	55.64
Earnings Date	n/a

About ViaDerma

ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company’s lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 75
• Stock Exchange: OTCMKTS
• Ticker Symbol: VDRM

Financial Performance

In 2017, ViaDerma's revenue was $44,691, a decrease of -82.26% compared to the previous year's $251,981. Losses were -$1.52 million, 1146.6% more than in 2016.